|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Iden- tification of driver mutation in specimens from 1000 pa- tients with lung adenocarcinoma: The NCI' s Lung Cancer Mutation Consortium ( LCMC ) AbstractCRA7506 显示文摘 | Kris M G Johnson B E Kwiatkowski D J | 2011 | J Clin 0ncol2011，29，20： | 1 |
| 2 | Can infant feeding choices modulate later obesity risk?显示文摘 | Koletzko B van Kries R Closa R | 2009 | The American Journal of Clinical Nutrition2009，89，5： | 1 |
| 3 | Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus 显示文摘 | Riely GJ Kris MG Zhao B | 2007 | Clin Cancer Res2007，13，17： | 1 |
| 4 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyorsinekinase, in symptomatic patients with non-small cell lung cancer: randomized tfial 显示文摘 | Kris M G Natale R B Herbst R S | 2003 | JAMA2003，290，16： | 1 |
| 5 | Lower protein in infant formula is associated with lower weight up to ag 2 y: A randomized clinical trial显示文摘 | Koletzko B yon Kries R C10sa R | 2009 | The American Journal of Clinical Nutrition2009，89，6： | 1 |
| 6 | Lung cancer in US women: a contemporary epidemic 显示文摘 | PATEL J D BACH P B KRIS M G | 2004 | J Am Med Assoc2004，291，14： | 1 |
| 7 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial显示文摘 | Kris M G Natale R B Herbst R S | 2003 | JAMA2003，290，16： | 1 |
| 8 | Efficacy of gefitinib, aninhibitor of the epidermal growth factor receptor tyrosine kinase, insymptomatic patients with non-small cell lung cancer: a randomized trial显示文摘 | Kris M G Natale R B Herbst R S | 2003 | JAMA2003，290，16： | 1 |
| 9 | The Structure of Aqueous Solutions of Some Dihydrogen Orthophosphates by Laser Raman Spectroscopy 显示文摘 | Michael K C Kris A B | 1987 | Journal of Crystal Growth1987，84，4： | 1 |
| 10 | Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinih fol- lowed by the addition of everolimus 显示文摘 | Riely G J Kris MG Zhao B et o2 | 2007 | Clin Cancer Res2007，13，： | 1 |
| 11 | Identifying children athigh risk for overweight at school entry by weight gain during the first2years显示文摘 | Toschke A Grote V Koletzko B von Kries R | 2004 | Arch Pediatr Adolesc Med2004，，158： | 1 |
| 12 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non small cell lung cancer: a randomized trial显示文摘 | Kris M G Natale R B Herbst R S | 2003 | J Am Med Assoc2003，290，16： | 1 |
| 13 | Efficacy of gefitinib, and inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non small-cell lung cancer:a randomized trial显示文摘 | Kris M G Natale R B Herbst R S | 2003 | JAMA2003，290，： | 1 |
| 14 | Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus显示文摘 | Riely GJ Kris MG Zhao B | | 0，，17： | 1 |
| 15 | Efficacy of gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,insymptomatic patients with non-small cell lung cancer:a randomized trial显示文摘 | Kris M G Natale R B Herbst R S | 2003 | JAMA2003，290，16： | 1 |
| 16 | A phase II trial of ZD1839(Iressa)in advanced non-small cell lung eancer(NSCLC)patients who had failed platinum and doeetaxel-based regimens(IDEAL 2)显示文摘 | Kris R B Natale R S Herbst T J | 2002 | Proe Am Soe Clin Oncol2002，21，： | 1 |
| 17 | Expression of Guanylin Is Downregulated in Mouse and Human Intestinal Adenomas显示文摘 | Kris A Steinbrecher Thérèse M.F Tuohy Kathleen Heppner Goss M.Catherine Scott David P Witte Joanna Groden Mitchell B Cohen | 2000 | Biochemical and Biophysical Research Communications2000，，1： | 1 |
| 18 | Efficacy of Gefitinib,an i-nhibitor of the epidermal growth factor receptor tyrosine nase,in symptomatic patients with non2smaU cell lung cancer显示文摘 | Natale R B Herbst R S | 2003 | JAMA2003，290，6： | 1 |
| 19 | Identifi- cation of driver mutations in tumor specimens from 1000 patients with lung adenocarcinoma:The NCI's Lung Canc- er Mutation Consortium(LCMC)显示文摘 | Kris M G Johnson B E Kwiatkowski D J | 2012 | J Clin Oncol2012，，47： | 1 |
| 20 | Efficacy of Gefitinib an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase in Symptomatic Patients with Non-small Cell Lung Cancer Randomized Trial 显示文摘 | Kris M G Natale R B Herbst R S | 2002 | JAMA2002，290，16： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员